F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Hepatic steatosis

Page 1 of 2 ( 65 items )
<<
1
2
>>

1	Gluten’s silent strike: Unmasking its impact on liver health 12/22/2025 7:43:02 AM \| Browse: 9 \| Download: 37
2	Fatty liver reexamined choline and mitochondrial toxin amelioration 12/4/2025 6:40:47 AM \| Browse: 24 \| Download: 67
3	Machine learning to predict metabolic-associated fatty liver disease 12/3/2025 9:10:07 AM \| Browse: 24 \| Download: 107
4	Bile acids in metabolic dysfunction-associated steatotic liver disease 8/27/2025 9:21:12 AM \| Browse: 150 \| Download: 266
5	Nutrients as epigenetic modulators in metabolic dysfunction-associated steatotic liver disease 8/27/2025 9:21:11 AM \| Browse: 136 \| Download: 273
6	Copper and hepatic lipid dysregulation: Mechanisms and implications 8/27/2025 9:21:08 AM \| Browse: 64 \| Download: 152
7	Duodenal mucosal ablation: An emerging therapeutic concept for metabolic dysfunction-associated fatty liver disease 7/24/2025 7:47:21 AM \| Browse: 48 \| Download: 118
8	Machine learning-based identification of biochemical markers to predict hepatic steatosis in patients at high metabolic risk 7/21/2025 9:42:33 AM \| Browse: 46 \| Download: 232
9	Extracellular vesicles as biomarkers for metabolic dysfunction-associated steatotic liver disease staging using explainable artificial intelligence 6/12/2025 3:45:50 AM \| Browse: 55 \| Download: 371
10	Bicuculline ameliorates metabolic dysfunction-associated steatotic liver disease by inhibiting the nuclear factor-kappa B pathway and reducing lipid accumulation 4/29/2025 9:13:41 AM \| Browse: 65 \| Download: 411
11	Correlation of liver imaging and transient elastography among patients with hepatitis C at a safety net hospital 4/25/2025 8:23:05 AM \| Browse: 92 \| Download: 428
12	Role of 1,25-dihydroxyvitamin D3 in alleviating hepatic steatosis: Targeting M1 macrophage polarization in non-alcoholic fatty liver disease 2/14/2025 10:33:16 AM \| Browse: 102 \| Download: 452
13	Inhibition of metabotropic glutamate receptor-5 alleviates hepatic steatosis by enhancing autophagy via activation of the AMPK signaling pathway 1/20/2025 7:38:46 AM \| Browse: 56 \| Download: 419
14	Pathogenesis and research progress of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 10/21/2024 7:03:24 AM \| Browse: 140 \| Download: 513
15	Hepatoprotective effects of Xiaoyao San formula on hepatic steatosis and inflammation via regulating the sex hormones metabolism 7/26/2024 10:33:30 AM \| Browse: 153 \| Download: 929
16	Liver disease in patients with transfusion-dependent β-thalassemia: The emerging role of metabolism dysfunction-associated steatotic liver disease 5/22/2024 11:33:24 AM \| Browse: 81 \| Download: 484
17	Two-point Dixon and six-point Dixon magnetic resonance techniques in the detection, quantification and grading of hepatic steatosis 10/24/2023 7:40:57 AM \| Browse: 238 \| Download: 825
18	Peroxisome proliferator-activated receptors as targets to treat metabolic diseases: Focus on the adipose tissue, liver, and pancreas 7/10/2023 8:58:21 AM \| Browse: 430 \| Download: 1120
19	Non-invasive evaluation of liver steatosis with imaging modalities: New techniques and applications 5/7/2023 7:47:34 AM \| Browse: 389 \| Download: 1066
20	Metabolic dysfunction associated fatty liver disease: The new nomenclature and its impact 1/12/2023 10:19:09 AM \| Browse: 415 \| Download: 1287
21	Hepatic steatosis with mass effect: A case report 10/21/2022 2:24:59 AM \| Browse: 590 \| Download: 2028
22	Interplay between metabolic dysfunction-associated fatty liver disease and chronic kidney disease: Epidemiology, pathophysiologic mechanisms, and treatment considerations 10/18/2022 8:29:59 AM \| Browse: 650 \| Download: 1335
23	Growing challenge of post-liver transplantation non-alcoholic fatty liver disease 9/13/2022 3:28:02 AM \| Browse: 729 \| Download: 1659
24	Nonalcoholic fatty liver disease and diabetes 9/9/2022 3:45:24 PM \| Browse: 679 \| Download: 1630
25	Higher cardiovascular risk scores and liver fibrosis risk estimated by biomarkers in patients with metabolic-dysfunction-associated fatty liver disease 8/26/2022 9:51:35 AM \| Browse: 588 \| Download: 1309
26	Metabolic dysfunction is associated with steatosis but no other histologic features in nonalcoholic fatty liver disease 4/30/2022 5:08:22 AM \| Browse: 616 \| Download: 1857
27	Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations 4/22/2022 10:52:23 AM \| Browse: 637 \| Download: 1577
28	Hepatobiliary manifestations in inflammatory bowel disease: A practical approach 2/22/2022 9:25:37 AM \| Browse: 468 \| Download: 1146
29	Influencing factors for hepatic fat accumulation in patients with type 2 diabetes mellitus 9/10/2021 7:23:16 AM \| Browse: 565 \| Download: 1860
30	Metabolic and cardiovascular complications after virological cure in hepatitis C: What awaits beyond 4/29/2021 2:12:02 AM \| Browse: 631 \| Download: 1554
31	Evaluation of controlled attenuation parameter in assessing hepatic steatosis in patients with autoimmune liver diseases 12/30/2020 1:59:10 PM \| Browse: 760 \| Download: 2205
32	MANF ameliorates steatosis in HepG2 cells by regulating hepatic lipid metabolism 3/14/2020 3:03:29 PM \| Browse: 1019 \| Download: 2246
33	Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease via the Sirt1/AMPK and NF-κB signaling pathways 9/12/2019 8:50:34 AM \| Browse: 852 \| Download: 2426
34	Accuracy of multi-echo Dixon sequence in quantification of hepatic steatosis in Chinese children and adolescents 3/28/2019 9:14:41 AM \| Browse: 1217 \| Download: 2554
35	Ursodeoxycholic acid ameliorates hepatic lipid metabolism in LO2 cells by regulating the AKT/mTOR/SREBP-1 signaling pathway 3/28/2019 9:14:40 AM \| Browse: 1070 \| Download: 2113
36	Hemodynamic changes in hepatic sinusoids of hepatic steatosis mice 3/20/2019 5:32:10 AM \| Browse: 1086 \| Download: 2420
37	Risk factors for hepatic steatosis in adults with cystic fibrosis: Similarities to non-alcoholic fatty liver disease 1/26/2018 8:09:36 AM \| Browse: 969 \| Download: 2042
38	Clinical epidemiology and disease burden of nonalcoholic fatty liver disease 12/20/2017 2:49:19 AM \| Browse: 1618 \| Download: 2120
39	Fatty liver without a large “belly”: Magnified review of non-alcoholic fatty liver disease in non-obese patients 8/14/2017 1:56:00 AM \| Browse: 1276 \| Download: 2288
40	S-1 induced hepatic steatosis in patients with pancreatic cancer: Retrospective analysis 8/10/2017 11:54:13 PM \| Browse: 1485 \| Download: 2579
41	Is hepatic steatosis associated with left ventricular mass index increase in the general population? 7/5/2017 4:40:08 AM \| Browse: 1136 \| Download: 2653
42	Antioxidant dietary approach in treatment of fatty liver: New insights and updates 6/20/2017 12:12:52 PM \| Browse: 1338 \| Download: 2519
43	Embrionary way to create a fatty liver in portal hypertension 5/16/2017 6:56:36 AM \| Browse: 1473 \| Download: 2990
44	Chronic exposure to ethanol causes steatosis and inflammation in zebrafish liver 3/13/2017 1:20:00 PM \| Browse: 1377 \| Download: 2025
45	Sitagliptin in patients with non-alcoholic steatohepatitis: A randomized, placebo-controlled trial 1/5/2017 11:10:00 AM \| Browse: 1752 \| Download: 3568
46	Quality of life 10 years after liver transplantation: The impact of graft histology 12/14/2016 2:15:00 PM \| Browse: 1250 \| Download: 1759
47	Hepatic steatosis and fibrosis: Non-invasive assessment 12/6/2016 5:24:00 PM \| Browse: 1364 \| Download: 1911
48	Retrospective study of the associations between hepatitis C virus infection and metabolic factors 10/25/2016 8:46:00 AM \| Browse: 1770 \| Download: 2945
49	Steatotic livers are susceptible to normothermic ischemia-reperfusion injury from mitochondrial Complex-Ⅰ dysfunction 5/19/2016 9:54:00 AM \| Browse: 1229 \| Download: 2807
50	Fatty liver disease: Disparate predictive ability for cardiometabolic risk and all-cause mortality 12/24/2015 11:11:00 AM \| Browse: 1263 \| Download: 2096

Page 1 of 2 ( 65 items )
<<
1
2
>>

1	Gluten’s silent strike: Unmasking its impact on liver health 12/22/2025 7:43:02 AM \| Browse: 9 \| Download: 37
2	Fatty liver reexamined choline and mitochondrial toxin amelioration 12/4/2025 6:40:47 AM \| Browse: 24 \| Download: 67
3	Machine learning to predict metabolic-associated fatty liver disease 12/3/2025 9:10:07 AM \| Browse: 24 \| Download: 107
4	Bile acids in metabolic dysfunction-associated steatotic liver disease 8/27/2025 9:21:12 AM \| Browse: 150 \| Download: 266
5	Nutrients as epigenetic modulators in metabolic dysfunction-associated steatotic liver disease 8/27/2025 9:21:11 AM \| Browse: 136 \| Download: 273
6	Copper and hepatic lipid dysregulation: Mechanisms and implications 8/27/2025 9:21:08 AM \| Browse: 64 \| Download: 152
7	Duodenal mucosal ablation: An emerging therapeutic concept for metabolic dysfunction-associated fatty liver disease 7/24/2025 7:47:21 AM \| Browse: 48 \| Download: 118
8	Machine learning-based identification of biochemical markers to predict hepatic steatosis in patients at high metabolic risk 7/21/2025 9:42:33 AM \| Browse: 46 \| Download: 232
9	Extracellular vesicles as biomarkers for metabolic dysfunction-associated steatotic liver disease staging using explainable artificial intelligence 6/12/2025 3:45:50 AM \| Browse: 55 \| Download: 371
10	Bicuculline ameliorates metabolic dysfunction-associated steatotic liver disease by inhibiting the nuclear factor-kappa B pathway and reducing lipid accumulation 4/29/2025 9:13:41 AM \| Browse: 65 \| Download: 411
11	Correlation of liver imaging and transient elastography among patients with hepatitis C at a safety net hospital 4/25/2025 8:23:05 AM \| Browse: 92 \| Download: 428
12	Role of 1,25-dihydroxyvitamin D3 in alleviating hepatic steatosis: Targeting M1 macrophage polarization in non-alcoholic fatty liver disease 2/14/2025 10:33:16 AM \| Browse: 102 \| Download: 452
13	Inhibition of metabotropic glutamate receptor-5 alleviates hepatic steatosis by enhancing autophagy via activation of the AMPK signaling pathway 1/20/2025 7:38:46 AM \| Browse: 56 \| Download: 419
14	Pathogenesis and research progress of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 10/21/2024 7:03:24 AM \| Browse: 140 \| Download: 513
15	Hepatoprotective effects of Xiaoyao San formula on hepatic steatosis and inflammation via regulating the sex hormones metabolism 7/26/2024 10:33:30 AM \| Browse: 153 \| Download: 929
16	Liver disease in patients with transfusion-dependent β-thalassemia: The emerging role of metabolism dysfunction-associated steatotic liver disease 5/22/2024 11:33:24 AM \| Browse: 81 \| Download: 484
17	Two-point Dixon and six-point Dixon magnetic resonance techniques in the detection, quantification and grading of hepatic steatosis 10/24/2023 7:40:57 AM \| Browse: 238 \| Download: 825
18	Peroxisome proliferator-activated receptors as targets to treat metabolic diseases: Focus on the adipose tissue, liver, and pancreas 7/10/2023 8:58:21 AM \| Browse: 430 \| Download: 1120
19	Non-invasive evaluation of liver steatosis with imaging modalities: New techniques and applications 5/7/2023 7:47:34 AM \| Browse: 389 \| Download: 1066
20	Metabolic dysfunction associated fatty liver disease: The new nomenclature and its impact 1/12/2023 10:19:09 AM \| Browse: 415 \| Download: 1287
21	Hepatic steatosis with mass effect: A case report 10/21/2022 2:24:59 AM \| Browse: 590 \| Download: 2028
22	Interplay between metabolic dysfunction-associated fatty liver disease and chronic kidney disease: Epidemiology, pathophysiologic mechanisms, and treatment considerations 10/18/2022 8:29:59 AM \| Browse: 650 \| Download: 1335
23	Growing challenge of post-liver transplantation non-alcoholic fatty liver disease 9/13/2022 3:28:02 AM \| Browse: 729 \| Download: 1659
24	Nonalcoholic fatty liver disease and diabetes 9/9/2022 3:45:24 PM \| Browse: 679 \| Download: 1630
25	Higher cardiovascular risk scores and liver fibrosis risk estimated by biomarkers in patients with metabolic-dysfunction-associated fatty liver disease 8/26/2022 9:51:35 AM \| Browse: 588 \| Download: 1309
26	Metabolic dysfunction is associated with steatosis but no other histologic features in nonalcoholic fatty liver disease 4/30/2022 5:08:22 AM \| Browse: 616 \| Download: 1857
27	Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations 4/22/2022 10:52:23 AM \| Browse: 637 \| Download: 1577
28	Hepatobiliary manifestations in inflammatory bowel disease: A practical approach 2/22/2022 9:25:37 AM \| Browse: 468 \| Download: 1146
29	Influencing factors for hepatic fat accumulation in patients with type 2 diabetes mellitus 9/10/2021 7:23:16 AM \| Browse: 565 \| Download: 1860
30	Metabolic and cardiovascular complications after virological cure in hepatitis C: What awaits beyond 4/29/2021 2:12:02 AM \| Browse: 631 \| Download: 1554
31	Evaluation of controlled attenuation parameter in assessing hepatic steatosis in patients with autoimmune liver diseases 12/30/2020 1:59:10 PM \| Browse: 760 \| Download: 2205
32	MANF ameliorates steatosis in HepG2 cells by regulating hepatic lipid metabolism 3/14/2020 3:03:29 PM \| Browse: 1019 \| Download: 2246
33	Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease via the Sirt1/AMPK and NF-κB signaling pathways 9/12/2019 8:50:34 AM \| Browse: 852 \| Download: 2426
34	Accuracy of multi-echo Dixon sequence in quantification of hepatic steatosis in Chinese children and adolescents 3/28/2019 9:14:41 AM \| Browse: 1217 \| Download: 2554
35	Ursodeoxycholic acid ameliorates hepatic lipid metabolism in LO2 cells by regulating the AKT/mTOR/SREBP-1 signaling pathway 3/28/2019 9:14:40 AM \| Browse: 1070 \| Download: 2113
36	Hemodynamic changes in hepatic sinusoids of hepatic steatosis mice 3/20/2019 5:32:10 AM \| Browse: 1086 \| Download: 2420
37	Risk factors for hepatic steatosis in adults with cystic fibrosis: Similarities to non-alcoholic fatty liver disease 1/26/2018 8:09:36 AM \| Browse: 969 \| Download: 2042
38	Clinical epidemiology and disease burden of nonalcoholic fatty liver disease 12/20/2017 2:49:19 AM \| Browse: 1618 \| Download: 2120
39	Fatty liver without a large “belly”: Magnified review of non-alcoholic fatty liver disease in non-obese patients 8/14/2017 1:56:00 AM \| Browse: 1276 \| Download: 2288
40	S-1 induced hepatic steatosis in patients with pancreatic cancer: Retrospective analysis 8/10/2017 11:54:13 PM \| Browse: 1485 \| Download: 2579
41	Is hepatic steatosis associated with left ventricular mass index increase in the general population? 7/5/2017 4:40:08 AM \| Browse: 1136 \| Download: 2653
42	Antioxidant dietary approach in treatment of fatty liver: New insights and updates 6/20/2017 12:12:52 PM \| Browse: 1338 \| Download: 2519
43	Embrionary way to create a fatty liver in portal hypertension 5/16/2017 6:56:36 AM \| Browse: 1473 \| Download: 2990
44	Chronic exposure to ethanol causes steatosis and inflammation in zebrafish liver 3/13/2017 1:20:00 PM \| Browse: 1377 \| Download: 2025
45	Sitagliptin in patients with non-alcoholic steatohepatitis: A randomized, placebo-controlled trial 1/5/2017 11:10:00 AM \| Browse: 1752 \| Download: 3568
46	Quality of life 10 years after liver transplantation: The impact of graft histology 12/14/2016 2:15:00 PM \| Browse: 1250 \| Download: 1759
47	Hepatic steatosis and fibrosis: Non-invasive assessment 12/6/2016 5:24:00 PM \| Browse: 1364 \| Download: 1911
48	Retrospective study of the associations between hepatitis C virus infection and metabolic factors 10/25/2016 8:46:00 AM \| Browse: 1770 \| Download: 2945
49	Steatotic livers are susceptible to normothermic ischemia-reperfusion injury from mitochondrial Complex-Ⅰ dysfunction 5/19/2016 9:54:00 AM \| Browse: 1229 \| Download: 2807
50	Fatty liver disease: Disparate predictive ability for cardiometabolic risk and all-cause mortality 12/24/2015 11:11:00 AM \| Browse: 1263 \| Download: 2096